DE759917T1 - Neue selektive inhibitoren viraler oder bakterieller neuraminidasen - Google Patents
Neue selektive inhibitoren viraler oder bakterieller neuraminidasenInfo
- Publication number
- DE759917T1 DE759917T1 DE0759917T DE96912404T DE759917T1 DE 759917 T1 DE759917 T1 DE 759917T1 DE 0759917 T DE0759917 T DE 0759917T DE 96912404 T DE96912404 T DE 96912404T DE 759917 T1 DE759917 T1 DE 759917T1
- Authority
- DE
- Germany
- Prior art keywords
- composition according
- group
- substituted
- stands
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940124639 Selective inhibitor Drugs 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 37
- -1 antibodies Substances 0.000 claims abstract 15
- 238000000034 method Methods 0.000 claims abstract 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 11
- 230000002378 acidificating effect Effects 0.000 claims abstract 9
- 102000005348 Neuraminidase Human genes 0.000 claims abstract 7
- 108010006232 Neuraminidase Proteins 0.000 claims abstract 7
- 230000000694 effects Effects 0.000 claims abstract 2
- 230000002401 inhibitory effect Effects 0.000 claims abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 42
- 239000001257 hydrogen Substances 0.000 claims 24
- 229910052799 carbon Inorganic materials 0.000 claims 19
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 19
- 229910052794 bromium Inorganic materials 0.000 claims 16
- 229910052801 chlorine Inorganic materials 0.000 claims 16
- 229910052731 fluorine Inorganic materials 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 125000004093 cyano group Chemical group *C#N 0.000 claims 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 12
- 150000003254 radicals Chemical class 0.000 claims 12
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 11
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 11
- 125000005842 heteroatom Chemical group 0.000 claims 10
- 229910052740 iodine Inorganic materials 0.000 claims 10
- 229910052757 nitrogen Inorganic materials 0.000 claims 10
- 125000000623 heterocyclic group Chemical group 0.000 claims 9
- 125000004419 alkynylene group Chemical group 0.000 claims 7
- 150000001408 amides Chemical class 0.000 claims 7
- 125000006239 protecting group Chemical group 0.000 claims 7
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims 6
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 claims 6
- 239000002253 acid Substances 0.000 claims 6
- 125000004450 alkenylene group Chemical group 0.000 claims 6
- 125000002947 alkylene group Chemical group 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 150000001721 carbon Chemical group 0.000 claims 3
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 claims 2
- 101100294106 Caenorhabditis elegans nhr-3 gene Proteins 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 claims 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 239000005864 Sulphur Substances 0.000 claims 2
- 208000036142 Viral infection Diseases 0.000 claims 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 2
- 230000003213 activating effect Effects 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 125000006244 carboxylic acid protecting group Chemical group 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 206010022000 influenza Diseases 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 150000003536 tetrazoles Chemical class 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- 125000000424 1,2-diol group Chemical group 0.000 claims 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 1
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 1
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims 1
- 241000282341 Mustela putorius furo Species 0.000 claims 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 1
- 150000004703 alkoxides Chemical class 0.000 claims 1
- 150000001409 amidines Chemical class 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000012024 dehydrating agents Substances 0.000 claims 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 claims 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 150000001335 aliphatic alkanes Chemical class 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39524595A | 1995-02-27 | 1995-02-27 | |
| US08/476,946 US5866601A (en) | 1995-02-27 | 1995-06-06 | Carbocyclic compounds |
| US58056795A | 1995-12-29 | 1995-12-29 | |
| PCT/US1996/002882 WO1996026933A1 (en) | 1995-02-27 | 1996-02-26 | Novel selective inhibitors of viral or bacterial neuraminidases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE759917T1 true DE759917T1 (de) | 1998-10-22 |
Family
ID=27410155
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69607704T Expired - Lifetime DE69607704T2 (de) | 1995-02-27 | 1996-02-26 | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
| DE2002199052 Pending DE10299052I1 (de) | 1995-02-27 | 1996-02-26 | Neue selektive Inhibitoren viraler oder bakterieller Neuraminidasen |
| DE69635231T Expired - Lifetime DE69635231T2 (de) | 1995-02-27 | 1996-02-26 | Selektive Inhibitoren viraler oder bakterieller Neuraminidase |
| DE0759917T Pending DE759917T1 (de) | 1995-02-27 | 1996-02-26 | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69607704T Expired - Lifetime DE69607704T2 (de) | 1995-02-27 | 1996-02-26 | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
| DE2002199052 Pending DE10299052I1 (de) | 1995-02-27 | 1996-02-26 | Neue selektive Inhibitoren viraler oder bakterieller Neuraminidasen |
| DE69635231T Expired - Lifetime DE69635231T2 (de) | 1995-02-27 | 1996-02-26 | Selektive Inhibitoren viraler oder bakterieller Neuraminidase |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US5952375A (enExample) |
| EP (1) | EP0759917B1 (enExample) |
| JP (3) | JP3300365B2 (enExample) |
| KR (1) | KR100447096B1 (enExample) |
| CN (2) | CN1185223C (enExample) |
| AT (2) | ATE191711T1 (enExample) |
| AU (1) | AU720933B2 (enExample) |
| BR (2) | BR9607098A (enExample) |
| CZ (1) | CZ297945B6 (enExample) |
| DE (4) | DE69607704T2 (enExample) |
| DK (1) | DK0759917T3 (enExample) |
| ES (2) | ES2249863T3 (enExample) |
| GR (1) | GR3033914T3 (enExample) |
| HU (1) | HU228450B1 (enExample) |
| LU (1) | LU90991I2 (enExample) |
| MX (1) | MX9706496A (enExample) |
| NL (1) | NL300105I2 (enExample) |
| NO (1) | NO318455B1 (enExample) |
| NZ (1) | NZ306625A (enExample) |
| PL (1) | PL194173B1 (enExample) |
| PT (1) | PT759917E (enExample) |
| RU (1) | RU2181357C2 (enExample) |
| SG (1) | SG45864A1 (enExample) |
| SI (1) | SI9620042A (enExample) |
| UA (1) | UA56128C2 (enExample) |
| WO (1) | WO1996026933A1 (enExample) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE191711T1 (de) * | 1995-02-27 | 2000-04-15 | Gilead Sciences Inc | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
| US5714509A (en) * | 1995-05-03 | 1998-02-03 | The University Of Alabama | Inhibitors of bacterial sialidase and methods of making and using the same |
| US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
| US6093816A (en) | 1996-06-27 | 2000-07-25 | Isis Pharmaceuticals, Inc. | Cationic lipids |
| US6518438B2 (en) | 1996-08-23 | 2003-02-11 | Gilead Sciences, Inc. | Preparation of cyclohexene carboxylate derivatives |
| US5859284A (en) * | 1996-08-23 | 1999-01-12 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| ATE215062T1 (de) * | 1996-08-23 | 2002-04-15 | Gilead Sciences Inc | Verfahren zur herstellung von cyclohexen- carboxylatderivate |
| EP0938475A1 (en) * | 1996-10-21 | 1999-09-01 | Gilead Sciences, Inc. | Piperidine compounds |
| US5994377A (en) * | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
| TR199901081T2 (xx) * | 1996-11-14 | 1999-08-23 | Biota Scientific Management Pty.Ltd. | Y�ntem ve bu y�ntemde kullan�lan yeni bile�imler. |
| WO1999006369A1 (en) * | 1997-08-01 | 1999-02-11 | University Of Florida | Neuraminidase inhibitors |
| US5886213A (en) * | 1997-08-22 | 1999-03-23 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| US20040053999A1 (en) * | 1997-09-17 | 2004-03-18 | Bischofberger Norbert W. | Novel compounds and methods for synthesis and therapy |
| IL134691A0 (en) * | 1997-09-17 | 2001-04-30 | Gilead Sciences Inc | Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
| TW477783B (en) * | 1997-12-12 | 2002-03-01 | Gilead Sciences Inc | Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same |
| CN1282316A (zh) * | 1997-12-17 | 2001-01-31 | 生物晶体药品股份有限公司 | 用作神经氨酸酶抑制剂的取代环戊烷和环戊烯化合物 |
| US6455571B1 (en) | 1998-04-23 | 2002-09-24 | Abbott Laboratories | Inhibitors of neuraminidases |
| WO1999054299A1 (en) * | 1998-04-23 | 1999-10-28 | Abbott Laboratories | Pyrrolidines as inhibitors of neuraminidases |
| US6518305B1 (en) | 1998-04-23 | 2003-02-11 | Abbott Laboratories | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| DE69900483T2 (de) * | 1998-05-13 | 2002-06-27 | F. Hoffmann-La Roche Ag, Basel | Verfahren zur Herstellung von Shikiminsäure und deren Derivate |
| WO2000029385A1 (en) * | 1998-11-13 | 2000-05-25 | Gilead Sciences, Inc. | 1,4,5,6-tetrahydro-pyridazine derivatives, their preparation and their use as neuraminidase inhibitors |
| AUPP913999A0 (en) * | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| EP1059283B1 (en) | 1999-06-11 | 2003-05-28 | F. Hoffmann-La Roche Ag | Process for preparing neuraminidase inhibitor ro-64-0796 |
| DE19930177B4 (de) | 1999-06-30 | 2007-02-08 | Nikolai Vladimirovich Bovin | Intermolekular assoziierende Verbindungen und deren Verwendung |
| BR0010525A (pt) * | 1999-10-19 | 2002-11-26 | Abbott Lab | cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase |
| US6593314B1 (en) * | 1999-10-19 | 2003-07-15 | Abbott Laboratories | Neuraminidase inhibitors |
| US6627396B1 (en) * | 1999-10-28 | 2003-09-30 | The Regents Of The University Of California | Influenza sensor |
| JP2001131144A (ja) * | 1999-11-02 | 2001-05-15 | Sagami Chem Res Center | ７−アザビシクロ［４．１．０］ヘプト−３−エン−３−カルボン酸エステル類の製造方法 |
| US6462226B1 (en) | 1999-12-03 | 2002-10-08 | Hoffmann-La Roche Inc. | Process for the preparation of 4,5-diamino shikimic acid derivatives |
| WO2001047906A1 (en) * | 1999-12-27 | 2001-07-05 | Sagami Chemical Research Center | Process for the production of 5-oxy-7-oxabicyclo-[4.1.0]hept-3-e ne-3-carboxylic acid esters |
| US8642051B2 (en) * | 2000-03-21 | 2014-02-04 | Suzanne Jaffe Stillman | Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s) |
| WO2001080892A1 (en) * | 2000-04-25 | 2001-11-01 | Sankyo Company, Limited | Preventives for influenza |
| GB0015324D0 (en) * | 2000-06-22 | 2000-08-16 | Biota Scient Management | Medicaments |
| CA2411153C (en) | 2000-06-27 | 2007-01-30 | Patrick Busson | Method for preparing a composition |
| AUPR001000A0 (en) | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| WO2002092555A1 (en) * | 2001-05-11 | 2002-11-21 | Sankyo Company, Limited | Sialic acid derivatives |
| US6964784B2 (en) | 2002-03-07 | 2005-11-15 | Optigenex, Inc. | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| RU2220739C1 (ru) * | 2002-08-30 | 2004-01-10 | Гапонюк Петр Яковлевич | Интраназальное средство |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| US7122684B2 (en) | 2003-03-13 | 2006-10-17 | Roche Colorado Corporation | Process for preparing 1,2-diamino compounds |
| NZ543864A (en) | 2003-06-16 | 2009-10-30 | Leuven K U Res & Dev | Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs |
| WO2007053792A2 (en) * | 2005-11-05 | 2007-05-10 | Amplyx Pharmaceuticals, Inc. | Improving the pharmacokinetics of protease inhibitors and other drugs |
| ATE510813T1 (de) * | 2005-11-25 | 2011-06-15 | Hetero Drugs Ltd | Verbessertes verfahren für oseltamivirphosphat |
| KR100819759B1 (ko) | 2005-12-01 | 2008-04-07 | (주)파인켐 | 아자이드 화합물의 폭발성을 제거한 공정을 이용한 1,2-다이아미노 화합물 또는 이의 부가염 제조 방법 |
| WO2007074091A2 (en) * | 2005-12-28 | 2007-07-05 | F. Hoffmann-La Roche Ag | Epoxide intermediate in the tamiflu synthesis |
| ZA200806356B (en) | 2006-02-20 | 2009-11-25 | Chugai Pharmaceutical Co Ltd | Pharmaceutical composition comprising oseltamivir phosphate |
| US20080063722A1 (en) * | 2006-09-08 | 2008-03-13 | Advanced Inhalation Research, Inc. | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
| US20080306098A1 (en) * | 2006-11-06 | 2008-12-11 | Mutz Mitchell W | Pharmacokinetics of protease inhibitors and other drugs |
| JP5345073B2 (ja) | 2007-01-23 | 2013-11-20 | テラピコン エス．アール．エル． | 抗ウイルス化合物 |
| US20080194801A1 (en) * | 2007-02-14 | 2008-08-14 | Swanson Basil I | Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses |
| EP2145010A1 (en) | 2007-04-13 | 2010-01-20 | Monsanto Technology, LLC | Use of glyphosate to produce shikimic acid in microorganisms |
| US20090054334A1 (en) * | 2007-05-23 | 2009-02-26 | Mutz Mitchell W | Combinatorial improvement of bifunctional drug properties |
| EP2190439B1 (en) * | 2007-08-31 | 2016-03-09 | Academia Sinica | Oseltamivir phosphonate derivatives with anti-influenza activity and synthesis thereof |
| WO2009052303A2 (en) * | 2007-10-16 | 2009-04-23 | Monsanto Technology Llc | Processes for producing and recovering shikimic acid |
| US20100284993A1 (en) * | 2007-10-24 | 2010-11-11 | Mutz Mitchell W | Enhancing the Efficacy of Anti-Infective Therapeutics |
| WO2009078813A1 (en) * | 2007-12-19 | 2009-06-25 | Nanyang Technological University | Method of forming oseltamivir and derivatives thereof |
| US8334319B2 (en) * | 2008-01-04 | 2012-12-18 | Roche Palo Alto Llc | Polymorphic forms of oseltamivir phosphate |
| US20100081713A1 (en) * | 2008-03-19 | 2010-04-01 | CombinatoRx, (Singapore) Pte. Ltd. | Compositions and methods for treating viral infections |
| US20120058937A9 (en) | 2008-04-15 | 2012-03-08 | Tsrl, Inc. | Prodrugs of Neuraminidase Inhibitors |
| TWI491416B (zh) | 2008-12-24 | 2015-07-11 | Daiichi Sankyo Co Ltd | 吸入用乾燥粉末醫藥組成物 |
| CN101486664B (zh) * | 2008-12-31 | 2013-09-04 | 北京大学深圳研究生院 | 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物 |
| SG176056A1 (en) | 2009-05-15 | 2011-12-29 | Redx Pharma Ltd | Redox drug derivatives |
| WO2011021223A2 (en) * | 2009-08-19 | 2011-02-24 | Msn Laboratories Limited | Novel salts of ethyl (3r, 4s, 5r)-4,5-imino-3-(l-ethylpropoxy)-1- cvclohexene-1-carboxylate and its use |
| JP5837502B2 (ja) * | 2009-11-11 | 2015-12-24 | スリーエム イノベイティブ プロパティズ カンパニー | ポリマー組成物並びにその製造方法及び物品 |
| IT1396620B1 (it) | 2009-11-25 | 2012-12-14 | Therapicon Srl | Analoghi chimerici |
| EA201300142A1 (ru) | 2010-07-16 | 2013-08-30 | Гриндекс, Джоинт Сток Кампани | Производные 1,4-дигидропиридина, обладающие противовирусной эффективностью |
| AT510585B1 (de) | 2010-11-18 | 2012-05-15 | Apeptico Forschung & Entwicklung Gmbh | Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase |
| KR101369584B1 (ko) | 2011-04-19 | 2014-03-06 | 일양약품주식회사 | 페닐-이속사졸 유도체 및 그의 제조방법 |
| EP2578218A1 (en) | 2011-10-06 | 2013-04-10 | Grindeks, A Joint Stock Company | Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives |
| DE102011117128A1 (de) * | 2011-10-28 | 2013-05-02 | Christian-Albrechts-Universität Zu Kiel | Verbindungen zur Therapie der Influenza |
| RU2469020C1 (ru) * | 2011-11-08 | 2012-12-10 | Александр Васильевич Иващенко | (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения |
| RU2489422C1 (ru) * | 2012-05-12 | 2013-08-10 | Александр Васильевич Иващенко | Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси)циклогексен-1-карбоновые кислоты, их эфиры и способ применения |
| RU2521593C1 (ru) * | 2013-02-27 | 2014-06-27 | Общество с ограниченной ответственностью "Интеллектуальный Диалог" | Моно и дифторзамещенные этил (3r,4r,5s)-5-азидо-4-ацетиламино-3-(1-этилпропокси)-циклогексен-1-карбоксилаты, способ получения и применения |
| JP6453050B2 (ja) * | 2013-11-15 | 2019-01-16 | 国立大学法人富山大学 | ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法 |
| CN103819357B (zh) * | 2014-01-28 | 2016-03-16 | 浙江大学 | (-)-有效霉醇叠氮四乙酸酯的制备方法 |
| BR112016018571A2 (pt) | 2014-02-14 | 2017-10-17 | Toa Eiyo Ltd | composto de hidrocarboneto cíclico |
| AU2015260841A1 (en) | 2014-05-12 | 2016-12-01 | Glaxosmithkline Intellectual Property (No. 2) Limited | Pharmaceutical compositions comprising danirixin for treating infectious diseases |
| US9392814B2 (en) | 2014-06-06 | 2016-07-19 | Nicholas J. Singer | Delivery system for drinks |
| GB2532178A (en) * | 2014-06-09 | 2016-05-18 | Redx Pharma Plc | Antiviral compounds |
| IL296496B2 (en) | 2014-12-26 | 2024-10-01 | Univ Emory | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| USD773313S1 (en) | 2015-06-23 | 2016-12-06 | Nicholas J. Singer | Package |
| WO2017106820A1 (en) * | 2015-12-17 | 2017-06-22 | Thomas Jefferson University | Antiviral agents for drug-resistant influenza a |
| KR102339817B1 (ko) | 2016-06-30 | 2021-12-16 | 한미약품 주식회사 | 오셀타미비어 함유 경구용 고형제제 및 그 제조방법 |
| JP6249434B1 (ja) * | 2016-08-10 | 2017-12-20 | 塩野義製薬株式会社 | 置換された多環性ピリドン誘導体およびそのプロドラッグを含有する医薬組成物 |
| RS66222B1 (sr) | 2017-12-07 | 2024-12-31 | Univ Emory | N4-hidroksicitidin i derivati i antivirusne upotrebe povezane sa njim |
| KR20200106607A (ko) | 2019-03-05 | 2020-09-15 | 주식회사 코아팜바이오 | 오셀타미비르 함유 의약 조성물 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968788A (en) * | 1986-04-04 | 1990-11-06 | Board Of Regents, The University Of Texas System | Biologically reversible phosphate and phosphonate protective gruops |
| US5206400A (en) * | 1986-07-07 | 1993-04-27 | Ohio State University | Diastereomeric mono- and di-substituted diamino cyclohexane compounds and the method of preparation thereof |
| AU2947889A (en) * | 1988-01-12 | 1989-08-11 | Board Of Regents, The University Of Texas System | Histamine release inhibitory factor and preparations therefore |
| US5175273A (en) * | 1988-07-01 | 1992-12-29 | Genentech, Inc. | Nucleic acid intercalating agents |
| US5270340A (en) * | 1988-12-27 | 1993-12-14 | Bayer Aktiengesellschaft | Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents |
| GB2238049A (en) * | 1989-11-22 | 1991-05-22 | Ki Nii Epidemiologii I Infekts | Method for preparing inhibitor for influenza virus neuraminidase |
| CZ288492B6 (en) * | 1990-04-24 | 2001-06-13 | Biota Scient Management | Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon |
| WO1992006691A1 (en) * | 1990-10-19 | 1992-04-30 | Biota Scientific Management Pty. Ltd. | Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus |
| DE4033415A1 (de) * | 1990-10-20 | 1992-04-23 | Bayer Ag | Antimikrobielle mittel sowie substituierte 2-cyclohexan-1-yl-amin-derivate und deren herstellung |
| DE4131311A1 (de) * | 1991-09-20 | 1993-04-01 | Basf Ag | Dihydropyranderivate und diese enthaltende pflanzenschutzmittel |
| AU659501B2 (en) * | 1991-10-23 | 1995-05-18 | Biota Scientific Management Pty Ltd | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid |
| GB9126725D0 (en) * | 1991-12-17 | 1992-02-12 | Glaxo Group Ltd | Process |
| FR2687674B1 (fr) * | 1992-02-07 | 1995-05-19 | Roussel Uclaf | Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
| US5292938A (en) * | 1992-04-13 | 1994-03-08 | Associated Universities, Inc. | Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging |
| US5633360A (en) | 1992-04-14 | 1997-05-27 | Gilead Sciences, Inc. | Oligonucleotide analogs capable of passive cell membrane permeation |
| GB9220241D0 (en) * | 1992-09-25 | 1992-11-11 | Glaxo Group Ltd | Process |
| GB9220327D0 (en) * | 1992-09-25 | 1992-11-11 | Glaxo Group Ltd | Process |
| US5639786A (en) * | 1992-12-04 | 1997-06-17 | Biota Scientific Management, Pty., Ltd. | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid |
| US5514798A (en) * | 1993-06-02 | 1996-05-07 | Gilead Sciences, Inc. | Method and cyclic carbonates for nucleotide analogues |
| GB9311892D0 (en) * | 1993-06-09 | 1993-07-28 | Glaxo Wellcome Australia Ltd | Device |
| GB9311873D0 (en) * | 1993-06-09 | 1993-07-28 | Glaxo Group Ltd | Process |
| GB9312531D0 (en) * | 1993-06-17 | 1993-08-04 | Glaxo Group Ltd | Process |
| GB9325841D0 (en) * | 1993-12-17 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
| GB9400206D0 (en) * | 1994-01-07 | 1994-03-02 | Glaxo Group Ltd | Chemical compound |
| AUPM354694A0 (en) * | 1994-01-27 | 1994-02-17 | Biota Scientific Management Pty Ltd | Chemical compounds |
| US5985859A (en) * | 1994-04-14 | 1999-11-16 | The University Of Alabama | Methods of inhibiting bacterial sialidase |
| GB9410817D0 (en) * | 1994-05-28 | 1994-07-20 | Glaxo Group Ltd | Medicaments |
| AUPM725794A0 (en) * | 1994-08-03 | 1994-08-25 | Biota Scientific Management Pty Ltd | Chemical compounds |
| US5556963A (en) * | 1994-08-05 | 1996-09-17 | Oklahoma Medical Research Foundation | Synthesis of 4-alkoxy-N-acetylneuraminic acid |
| GB9416365D0 (en) * | 1994-08-12 | 1994-10-05 | Glaxo Group Ltd | Medicaments |
| US5512596A (en) * | 1994-09-02 | 1996-04-30 | Gilead Sciences, Inc. | Aromatic compounds |
| EP0789695A2 (en) | 1994-11-04 | 1997-08-20 | Gilead Sciences, Inc. | Thiepane compounds inhibiting and detecting hiv protease |
| ATE191711T1 (de) * | 1995-02-27 | 2000-04-15 | Gilead Sciences Inc | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
| US5866601A (en) * | 1995-02-27 | 1999-02-02 | Gilead Sciences, Inc. | Carbocyclic compounds |
| US5602277A (en) * | 1995-03-30 | 1997-02-11 | Biocryst Pharmaceuticals, Inc. | Substituted benzene derivatives useful as neuraminidase inhibitors |
| US5714509A (en) * | 1995-05-03 | 1998-02-03 | The University Of Alabama | Inhibitors of bacterial sialidase and methods of making and using the same |
| JP4162712B2 (ja) * | 1995-05-19 | 2008-10-08 | バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド | ６−カルボキサミドジヒドロピラン誘導体 |
| GB9510141D0 (en) | 1995-05-19 | 1995-07-12 | Biota Scient Management | Chemical compounds |
| GB9525389D0 (en) | 1995-12-12 | 1996-02-14 | Biota Scient Management Ltd | Chemical compounds |
| GB9516276D0 (en) | 1995-08-08 | 1995-10-11 | Biota Scient Management | Chemical compounds |
| US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
| ATE215062T1 (de) | 1996-08-23 | 2002-04-15 | Gilead Sciences Inc | Verfahren zur herstellung von cyclohexen- carboxylatderivate |
| US5859284A (en) | 1996-08-23 | 1999-01-12 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| US5948816A (en) * | 1996-09-10 | 1999-09-07 | Daikin Industries, Ltd. | 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds |
| US5886213A (en) | 1997-08-22 | 1999-03-23 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
-
1996
- 1996-02-26 AT AT96912404T patent/ATE191711T1/de active
- 1996-02-26 NZ NZ306625A patent/NZ306625A/xx not_active IP Right Cessation
- 1996-02-26 KR KR1019970705932A patent/KR100447096B1/ko not_active Expired - Lifetime
- 1996-02-26 SG SG1997004840A patent/SG45864A1/en unknown
- 1996-02-26 DE DE69607704T patent/DE69607704T2/de not_active Expired - Lifetime
- 1996-02-26 JP JP52644296A patent/JP3300365B2/ja not_active Expired - Lifetime
- 1996-02-26 DK DK96912404T patent/DK0759917T3/da active
- 1996-02-26 BR BR9607098A patent/BR9607098A/pt not_active IP Right Cessation
- 1996-02-26 EP EP96912404A patent/EP0759917B1/en not_active Expired - Lifetime
- 1996-02-26 ES ES99117934T patent/ES2249863T3/es not_active Expired - Lifetime
- 1996-02-26 WO PCT/US1996/002882 patent/WO1996026933A1/en not_active Ceased
- 1996-02-26 MX MX9706496A patent/MX9706496A/es unknown
- 1996-02-26 SI SI9620042A patent/SI9620042A/sl not_active IP Right Cessation
- 1996-02-26 CN CNB961901330A patent/CN1185223C/zh not_active Expired - Lifetime
- 1996-02-26 HU HU9800026A patent/HU228450B1/hu unknown
- 1996-02-26 DE DE2002199052 patent/DE10299052I1/de active Pending
- 1996-02-26 PL PL96322000A patent/PL194173B1/pl unknown
- 1996-02-26 AT AT99117934T patent/ATE305453T1/de active
- 1996-02-26 CZ CZ0269097A patent/CZ297945B6/cs not_active IP Right Cessation
- 1996-02-26 DE DE69635231T patent/DE69635231T2/de not_active Expired - Lifetime
- 1996-02-26 RU RU97116714/04A patent/RU2181357C2/ru active
- 1996-02-26 PT PT96912404T patent/PT759917E/pt unknown
- 1996-02-26 DE DE0759917T patent/DE759917T1/de active Pending
- 1996-02-26 ES ES96912404T patent/ES2118674T3/es not_active Expired - Lifetime
- 1996-02-26 US US08/606,624 patent/US5952375A/en not_active Expired - Lifetime
- 1996-02-26 BR BRPI9607098-6B8D patent/BR9607098B8/pt unknown
- 1996-02-26 AU AU53571/96A patent/AU720933B2/en not_active Expired
- 1996-02-26 UA UA97094796A patent/UA56128C2/uk unknown
- 1996-02-26 CN CNB011247142A patent/CN100409844C/zh not_active Expired - Lifetime
- 1996-05-24 US US08/653,034 patent/US20050176758A1/en not_active Abandoned
-
1997
- 1997-08-26 NO NO19973908A patent/NO318455B1/no not_active IP Right Cessation
-
1999
- 1999-04-08 US US09/288,091 patent/US6225341B1/en not_active Expired - Lifetime
-
2000
- 2000-07-07 GR GR20000401599T patent/GR3033914T3/el unknown
-
2001
- 2001-08-24 JP JP2001255372A patent/JP4234917B2/ja not_active Expired - Lifetime
-
2002
- 2002-10-29 NL NL300105C patent/NL300105I2/nl unknown
- 2002-12-11 LU LU90991C patent/LU90991I2/fr unknown
-
2005
- 2005-07-15 JP JP2005207906A patent/JP2006036770A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE759917T1 (de) | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen | |
| TW418196B (en) | Benzimidazole derivatives, their preparation and their use for the treatment or prophylaxis of viral infections | |
| DE69202243T2 (de) | 2,4-Diaminochinazolin-Derivate, um die Antitumorwirkung zu erhöhen. | |
| CA2024880A1 (en) | 10-(1-hydroxyethyl)-11-oxo-1-azatricyclo(7.2.0.0.3,8)undec-2-ene-2-2-ca rboxylic acid derivatives | |
| US6387935B1 (en) | Polycyclic dihydrothiazoles having substituted alkyl radicals in the two-position, process for their preparation, and their use as pharmaceuticals | |
| OA09354A (fr) | "Nouveaux dérivés de l'amino pipéridine, de l'amino pyrrolidine et de l'amino perhydroazépine, leurs procédés de préparation, les compositions pharmaceutiques qui les contiennent". | |
| ATE34984T1 (de) | Imidazo-heterocyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| FI895007A0 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi | |
| KR920016424A (ko) | 2-치환 퀴놀린, 이들의 제조 방법 및 의약으로서의 이들의 용도 | |
| OA08825A (fr) | Nouveaux dérivés de l'amino tétrahydro-5,6,7,8 naphto (2,3b) furanne, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. | |
| EP0580641A1 (de) | Neue thalidomidderivate, ein verfahren zu deren herstellung sowie die verwendung derselben in arzneimitteln. | |
| HUP9702509A2 (hu) | Kondenzált heterociklusos vegyületek aminocsoportjukon szubsztituált származékai, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| DE3765827D1 (de) | Gegebenenfalls substituierte, 1-(2'-(bis-(phenyl)-methoxy)-aethyl)-4-(3'-(bis-(phenyl)-methoxy)-propyl)-piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| US5631257A (en) | Benzoxazole derivatives | |
| DE3850603D1 (de) | Arylaralkylether, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung. | |
| DE9290039U1 (de) | Pyrimidinderivate zur Verbesserung der Anti-Tumor-Aktivität | |
| ES2344275T3 (es) | Nuevos (tio) carbamatos de benzimidazol con actividad antiparasitaria y sintesis de ellos. | |
| NO174851C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktiv hydroksyalkylfuranylderivater | |
| HUT68242A (en) | Process for preparing tiazolidinone and oxazolidinone derivatives, and pharmaceutical compositions containing them | |
| JPH0395156A (ja) | β―ラクタム誘導体 | |
| KR940011412A (ko) | α,ω-디아릴알칸 유도체, 그의 제조방법, 및 순환계 질환 및 정신병의 치료 및 예방용 용도. | |
| ATE30724T1 (de) | Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten. | |
| US5883255A (en) | Substituted indolizino 1,2-b!quinolinones | |
| NZ225528A (en) | Benzimidazoles substituted in the 2 position by n(4-n-guanidyl) piperidinyl radicals; preparations thereof; pharmaceutical compositions | |
| KR920004401A (ko) | 신규한 세팔로스포린 화합물과 그의 제조방법 |